Increased somatostatin response to glucagon in insulin-dependent diabetes mellitus
- PMID: 1687718
Increased somatostatin response to glucagon in insulin-dependent diabetes mellitus
Abstract
The dynamic study of somatostatin secretion was performed in patients with insulin-dependent diabetes mellitus and age- and sex matched volunteers. The basal levels of immunoreactive somatostatin, as well as its response to i.v. Glucagon (1 mg) at 10 and 20 min with consequent hyperglycemia were increased in most of diabetic patients as compared with the healthy controls. Our results suggest that the glucagon test could be used for estimating the somatostatin secretion in diabetes mellitus. This would reveal some impaired interactions between the endocrine function of the pancreas in diabetes mellitus.
Similar articles
-
Effect of a 12-hour subcutaneous infusion of somatostatin-14 on blood glucose, insulin and glucagon levels in healthy subjects and insulin dependent diabetics.Biomed Pharmacother. 1986;40(2):61-4. Biomed Pharmacother. 1986. PMID: 2875745
-
Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.Diabetologia. 2002 Aug;45(8):1111-9. doi: 10.1007/s00125-002-0878-6. Epub 2002 Jul 4. Diabetologia. 2002. PMID: 12189441
-
A case of fulminant type 1 diabetes mellitus with exocrine pancreatic insufficiency and enhanced glucagon response to meal ingestion.Diabetes Res Clin Pract. 2008 Nov;82(2):e1-4. doi: 10.1016/j.diabres.2008.08.004. Epub 2008 Sep 11. Diabetes Res Clin Pract. 2008. PMID: 18789550
-
Diabetes mellitus secondary to chronic pancreatitis.Dan Med Bull. 1993 Apr;40(2):153-62. Dan Med Bull. 1993. PMID: 8495594 Review.
-
[The artificial endocrine pancreas in clinical medicine and in research].Journ Annu Diabetol Hotel Dieu. 1976 May:279-96. Journ Annu Diabetol Hotel Dieu. 1976. PMID: 796524 Review. French. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Medical